The completion of the Human Genome Project in 2003 marked a turning point in medicine, sparking widespread optimism about a future where diseases could be predicted, prevented, and treated with ...

Since 1995, Nature Medicine has been chronicling advances in medical technology and health care. To mark the journal’s 30th anniversary, each month an issue of critical importance for the future of ...

Add Yahoo as a preferred source to see more of our stories on Google. URBANA, Ill. (WCIA) — Drugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss. GLP-1 medications were ...

How do cells know when to activate or slow down their activity? A team from the University of Geneva (UNIGE) provides new insights by studying TORC2, an essential but still poorly understood protein ...

Ebrahimi is a scientific leader at GSK. Mrksich is the Henry Wade Rogers professor at Northwestern University, where he is developing the MegaMolecule technology for creating multifunctional ...

Molecular glues are small, monovalent molecules that reshape an E3 ubiquitin ligase (E3) surface to promote a new protein-protein interaction with a target, triggering ubiquitination and removal by ...

When I first entered the field of lung cancer, the seminal study published in the New England Journal of Medicine was a four-arm chemotherapy doublet study that showed no difference in effectiveness.

“Aspirin is a drug that is readily available globally and extremely inexpensive compared to many modern cancer drugs, which ...

Modern cancer therapies have resulted in higher survival rates for victims of this dread disease, in many cases. However, their generic mode of delivery and action is associated with greater adverse ...

A new study has found comprehensive evidence that "weight-loss" GLP-1 receptor agonists such as semaglutide are effective in ...